Repatha and Morphine sulfate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Repatha (evolocumab) and Morphine sulfate (morphine sulfate). Common drug interactions include urticaria among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Repatha and Morphine sulfate. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Repatha?

Repatha has active ingredients of evolocumab. It is often used in high blood cholesterol. eHealthMe is studying from 156,256 Repatha users. Check the latest studies of Repatha.

What is Morphine sulfate?

Morphine sulfate has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 87,261 Morphine sulfate users. Check the latest studies of Morphine sulfate.



On Jul, 08, 2026

23 people who take Repatha and Morphine sulfate together, and have interactions are studied.

Repatha and Morphine sulfate drug interactions.

What are the common drug interactions of Repatha and Morphine Sulfate, by gender? *:

female:

  1. Urticaria (rash of round, red welts on the skin that itch intensely)
  2. Dyspnoea (difficult or laboured respiration)
  3. Fatigue (feeling of tiredness)
  4. Weight decreased
  5. Drug hypersensitivity
  6. Anaphylactic reaction (serious allergic reaction)
  7. Angioedema (rapid swelling of the dermis)
  8. Asthma
  9. Blood pressure systolic increased
  10. Body temperature decreased

male:

  1. Headache (pain in head)
  2. Chest pain
  3. Chronic kidney disease
  4. Pyrexia (fever)
  5. Renal failure (kidney dysfunction)
  6. Skin cancer
  7. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  8. Burning sensation
  9. Gastritis (inflammation of stomach)
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

What are the common drug interactions of Repatha and Morphine Sulfate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Angioedema (rapid swelling of the dermis)
  3. Asthma
  4. Blood pressure systolic increased
  5. Body temperature decreased
  6. Contusion (a type of hematoma of tissue in which capillaries)
  7. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  8. Drug hypersensitivity
  9. Dyspnoea (difficult or laboured respiration)
  10. Fatigue (feeling of tiredness)

50-59:

  1. Burning sensation
  2. Headache (pain in head)
  3. Abdominal pain
  4. Adverse event
  5. Angina pectoris (chest pain due to ischemia of the heart muscle)
  6. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  7. Arthralgia (joint pain)
  8. Cardiac murmur (an heart sound in valve abnormality)
  9. Drug ineffective
  10. Dysphagia (a condition in which swallowing is difficult or painful)

60+:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Urticaria (rash of round, red welts on the skin that itch intensely)
  3. Eye pain
  4. Eyelid irritation
  5. Gastrointestinal hypomotility (less activity of the intestinal tract)
  6. Haematoma (collection of blood outside the blood vessels)
  7. Lip and/or oral cavity cancer (cancer of lip or mouth)
  8. Neck mass (mass in neck)
  9. Renal disorder (kidney disease)
  10. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 17.39%
  2. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 17.39%
  3. Urticaria (rash of round, red welts on the skin that itch intensely): 3 people, 13.04%
  4. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 8.70%
  5. Migraine (headache): 2 people, 8.70%
  6. Immunodeficiency Common Variable: 2 people, 8.70%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.70%
  8. Diabetes: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Repatha and Morphine sulfate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Repatha and Morphine sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Repatha:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Morphine sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Repatha and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Morphine sulfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on evolocumab and morphine sulfate (the active ingredients of Repatha and Morphine sulfate, respectively), and Repatha and Morphine sulfate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: